AFCG Q4 2022: CECL Reserve Jumps 176% as Lending Shifts Toward 50% Non-Cannabis Mix
AFC Gamma sharply increased its credit reserves and is pivoting from a pure cannabis lender to a more diversified commercial real estate lender, seeking to capture higher yields and better risk-adjusted returns. Management is positioning AFCG to exploit the current void in real estate lending as banks retreat. Investors should watch for the pace and risk profile of non-cannabis loan growth through 2023.
Summary
- Credit Reserve Escalation: AFCG’s CECL reserve surged, reflecting heightened sector risk and proactive provisioning.
- Business Model Diversification: Non-cannabis commercial real estate lending is set to reach up to half the portfolio by year-end.
- Yield Preservation Focus: Management maintains high yield targets despite sector and macro headwinds.
Business Overview
AFC Gamma (AFCG) is a commercial mortgage REIT that provides senior secured loans, primarily to cannabis operators, but is now expanding into broader commercial real estate (CRE) lending. The company earns revenue from interest on loans, targeting high-yield, first-lien and second-lien debt. Its major segments are cannabis secured lending and, increasingly, non-cannabis CRE loans, with a strategic focus on risk-adjusted returns and capital preservation.
Performance Analysis
AFCG’s Q4 2022 results were shaped by both sector-specific headwinds and a strategic response to shifting market conditions. Distributable earnings comfortably covered the dividend, continuing a track record of out-earning shareholder payouts. However, the company’s Current Expected Credit Loss (CECL) reserve increased from 1.8% to 4.97% of loans at carrying value, a direct response to industry-wide pressures in cannabis and a prudent move as portfolio risk rises.
Loan originations in cannabis have paused for nine months as AFCG’s risk-adjusted return thresholds were not met, reflecting both discipline and the lack of attractive opportunities. The portfolio remains concentrated, with $401 million outstanding across 12 borrowers at year-end, but management highlighted a robust pipeline for non-cannabis CRE deals. The weighted average portfolio yield remained elevated at 21%, underscoring the company’s focus on high-return lending even as it diversifies.
- Reserve Buildup: The CECL reserve jump signals management’s caution and sector risk sensitivity.
- Dividend Sustainability: Distributable earnings exceeded dividends, supporting continued payout stability.
- Portfolio Mix Evolution: Non-cannabis originations are expected to materially reshape the loan book in 2023.
Overall, AFCG is prioritizing liquidity and risk management while seeking to capitalize on CRE lending dislocations.
Executive Commentary
"We have not originated any new cannabis debt investments that met our risk-adjusted return thresholds over the past nine months. We believe that cannabis 3.0 will emerge with well-capitalized and sophisticated opportunistic acquirers who will target purchasing existing cannabis assets at significantly reduced prices to form new competitive multi-state operators."
Leonard Tannenbaum, Chief Executive Officer
"As of December 31, 2022, the CECL Reserve represents approximately 4.97% of our loans at carrying value, compared to approximately 1.8% at September 30th, 2022. We currently have one borrower, Flower One, on non-accrual, which represents 0.9% of our portfolio."
Brett Kaufman, Chief Financial Officer
Strategic Positioning
1. Portfolio Diversification Beyond Cannabis
Management is actively pivoting to non-cannabis CRE lending, targeting multifamily, industrial, and retail properties. This shift is designed to reduce sector concentration risk and leverage broader lending opportunities as banks pull back from CRE.
2. Yield Discipline Amid Market Volatility
AFCG continues to target yields in the 12% to 20% range for new loans, with the current portfolio yield holding at 21%. This approach balances risk with the need to maintain attractive returns in a rising rate environment.
3. Conservative Underwriting and Leverage Strategy
The company is emphasizing low loan-to-value (LTV) and substantial equity cushions below its debt positions, prioritizing capital preservation and minimizing the risk of property takeovers. Management expects better leverage availability as non-cannabis assets grow in the mix.
4. Opportunistic Capital Deployment
AFCG is building liquidity and patience, waiting for CRE valuations to adjust and for new capital needs to emerge. The company anticipates a more balanced portfolio (potentially 50% non-cannabis) by year-end, depending on deal flow and market conditions.
Key Considerations
This quarter marks a significant inflection point for AFCG’s business model, as the company adapts to a challenging cannabis lending environment and seeks new growth avenues in CRE. Investors should focus on several critical factors as the transition unfolds:
Key Considerations:
- Reserve Expansion Reflects Sector Caution: The sharp increase in CECL reserves highlights AFCG’s recognition of elevated credit risk, especially in cannabis.
- CRE Lending Pipeline Maturation: The company expects to close its first non-cannabis CRE loan within 90 days, signaling imminent portfolio diversification.
- Bank Pullback Creates Opportunity: With traditional lenders exiting CRE, AFCG sees a sizable addressable market for alternative lending.
- Dividend Policy Remains Unchanged: Management reaffirms its commitment to payout ratios in the 85% to 100% range of distributable earnings, despite not receiving full market credit for the high yield.
Risks
Key risks include credit deterioration in the legacy cannabis portfolio, execution risk in scaling non-cannabis CRE lending, and macroeconomic volatility affecting real estate values and borrower health. Regulatory uncertainty in cannabis remains, while the pace and quality of new loan originations will test AFCG’s underwriting discipline. The company’s limited exposure to Michigan and avoidance of unlimited-license states partially mitigates sector risk, but cannot eliminate broader market pressures.
Forward Outlook
For Q1 2023, AFCG guided to:
- A fourth consecutive $0.56 dividend, payable April 14, 2023
- Continued focus on portfolio liquidity and prudent deployment in both cannabis and non-cannabis CRE loans
For full-year 2023, management maintained its dividend policy of 85% to 100% payout of distributable earnings, and expects the portfolio mix to approach a 50-50 balance between cannabis and non-cannabis CRE loans. Management emphasized patience, underwriting rigor, and a readiness to capitalize as CRE market dislocation intensifies.
- Non-cannabis loan closings anticipated in the next quarter
- Monitoring of credit quality and ongoing dialogue with borrowers
Takeaways
AFCG is navigating a sector transition with a clear focus on risk management and opportunistic capital deployment.
- Credit Reserve Surge: The 176% increase in the CECL reserve underscores management’s proactive stance toward rising credit risk and sector volatility.
- Strategic Diversification: The planned shift to a 50% non-cannabis CRE portfolio by year-end is a fundamental change, aiming to reduce concentration risk and tap into higher-yield opportunities as banks retreat.
- CRE Lending Execution Watch: Investors should monitor the pace, size, and risk profile of new non-cannabis loans, as well as any impact on leverage, yield, and dividend sustainability.
Conclusion
AFC Gamma is at a strategic crossroads, actively diversifying its lending book and increasing reserves to weather sector headwinds. The company’s ability to deploy capital into high-yield, lower-risk CRE loans while maintaining its dividend will determine its success in 2023 and beyond.
Industry Read-Through
AFCG’s pivot is a clear signal that cannabis lending has reached a risk inflection point, with capital scarcity and regulatory uncertainty driving both lenders and operators to retrench. The company’s move into CRE lending mirrors a broader industry trend, as alternative lenders capitalize on the void left by banks’ retreat from commercial real estate. Other specialty finance firms and REITs may follow suit, accelerating competition for high-yield, well-secured CRE loans. For cannabis operators and investors, tighter capital availability and higher credit standards will likely persist, shaping industry consolidation and asset repricing through 2023.